Nemaura Medical (NMRD) Stock: Climbing On Management Update

Nemaura Medical Inc (NASDAQ: NMRD) is flying early on in the trading session this morning, and for good reason. The company announced a management update, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The management update; what we’re seeing from the stock; and what we’ll be watching … Read more

Atossa Genetics (ATOS) Stock: Gaining On The Release Of Data

Atossa Genetics Inc (NASDAQ: ATOS) is having an overwhelmingly strong start to the trading session in the pre-market hours and for good reason. The company announced positive data with regard to a key clinical trial. Of course, this led to excitement among investors. Today, we’ll talk about the news, what we’re seeing from the stock, and … Read more

Skyline Medical (SKLN) Stock: Gaining Big On Sales Guidance

Skyline Medical Inc (NASDAQ: SKLN) is having an overwhelmingly strong trading session in the market this morning, and for good reason. The company announced updated projections with regard to the sale of its STREAMWAY System for the year 2018. The projections proved to be overwhelmingly positive, leading to excitement among investors and some serious gains in … Read more

Biotech Stock News (RPTP) (AERI) (CANF)

Raptor Pharmaceuticals (NASDAQ:RPTP) On Monday September 14, 2015 shares of Raptor Pharmaceuticals ended the day down 38% after the company announced that it had failed a phase 2b liver study in children with NASH — non-alcoholic steatohepatitis. The phase 2b trial enrolled up to 169 children with NASH between the ages of eight and seventeen. … Read more

Biotech Stock News (INO) (TTPH) (AKBA)

Inovio Pharmaceuticals (NASDAQ:INO)  On September 8, 2015 Inovio announced that it had dosed its first patient with its Universal HIV vaccine known as PennVax-GP. This trial is being run as a phase 1 trial that will assess the safety and tolerability of the vaccine in these patients with HIV. Although the phase 1 trial primarily … Read more

Biotech Stock News (IMGN) (RGLS) (GILD) (ACHN) (OPK) (BRLI)

Immunogen (NASDAQ:IMGN) Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy … Read more